256 related articles for article (PubMed ID: 12452861)
1. The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa.
Marchini G; Lindow S; Brismar H; Ståbi B; Berggren V; Ulfgren AK; Lonne-Rahm S; Agerberth B; Gudmundsson GH
Br J Dermatol; 2002 Dec; 147(6):1127-34. PubMed ID: 12452861
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense.
Yoshio H; Tollin M; Gudmundsson GH; Lagercrantz H; Jornvall H; Marchini G; Agerberth B
Pediatr Res; 2003 Feb; 53(2):211-6. PubMed ID: 12538777
[TBL] [Abstract][Full Text] [Related]
3. Urticaria Neonatorum: accumulation of tryptase-expressing mast cells in the skin lesions of newborns with Erythema Toxicum.
Nelson A; Ulfgren AK; Edner J; Ståbi B; Brismar H; Hultenby K; Marchini G
Pediatr Allergy Immunol; 2007 Dec; 18(8):652-8. PubMed ID: 18078419
[TBL] [Abstract][Full Text] [Related]
4. [Influence of neonatal and maternal factors on the prevalence of vernix caseosa].
Monteagudo B; Labandeira J; León-Muiños E; Romarís R; Ramírez-Santos A; González-Vilas D; Fernández-Prieto R; Toribio J
Actas Dermosifiliogr; 2011 Nov; 102(9):726-9. PubMed ID: 21481821
[TBL] [Abstract][Full Text] [Related]
5. Host defense proteins in vernix caseosa and amniotic fluid.
Akinbi HT; Narendran V; Pass AK; Markart P; Hoath SB
Am J Obstet Gynecol; 2004 Dec; 191(6):2090-6. PubMed ID: 15592296
[TBL] [Abstract][Full Text] [Related]
6. Erythema toxicum neonatorum: an immunohistochemical analysis.
Marchini G; Ulfgren AK; Loré K; Ståbi B; Berggren V; Lonne-Rahm S
Pediatr Dermatol; 2001; 18(3):177-87. PubMed ID: 11437996
[TBL] [Abstract][Full Text] [Related]
7. Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant.
Marchini G; Nelson A; Edner J; Lonne-Rahm S; Stavréus-Evers A; Hultenby K
Pediatr Res; 2005 Sep; 58(3):613-6. PubMed ID: 16148082
[TBL] [Abstract][Full Text] [Related]
8. AQP1 and AQP3, psoriasin, and nitric oxide synthases 1-3 are inflammatory mediators in erythema toxicum neonatorum.
Marchini G; Ståbi B; Kankes K; Lonne-Rahm S; Østergaard M; Nielsen S
Pediatr Dermatol; 2003; 20(5):377-84. PubMed ID: 14521551
[TBL] [Abstract][Full Text] [Related]
9. Vernix caseosa in neonatal adaptation.
Visscher MO; Narendran V; Pickens WL; LaRuffa AA; Meinzen-Derr J; Allen K; Hoath SB
J Perinatol; 2005 Jul; 25(7):440-6. PubMed ID: 15830002
[TBL] [Abstract][Full Text] [Related]
10. Neonatal skin maturation--vernix caseosa and free amino acids.
Visscher MO; Utturkar R; Pickens WL; LaRuffa AA; Robinson M; Wickett RR; Narendran V; Hoath SB
Pediatr Dermatol; 2011; 28(2):122-32. PubMed ID: 21504444
[TBL] [Abstract][Full Text] [Related]
11. Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions.
Tollin M; Bergsson G; Kai-Larsen Y; Lengqvist J; Sjövall J; Griffiths W; Skúladóttir GV; Haraldsson A; Jörnvall H; Gudmundsson GH; Agerberth B
Cell Mol Life Sci; 2005 Oct; 62(19-20):2390-9. PubMed ID: 16179970
[TBL] [Abstract][Full Text] [Related]
12. Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin.
Hoeger PH; Schreiner V; Klaassen IA; Enzmann CC; Friedrichs K; Bleck O
Br J Dermatol; 2002 Feb; 146(2):194-201. PubMed ID: 11903227
[TBL] [Abstract][Full Text] [Related]
13. Biology of the vernix caseosa: A review.
Nishijima K; Yoneda M; Hirai T; Takakuwa K; Enomoto T
J Obstet Gynaecol Res; 2019 Nov; 45(11):2145-2149. PubMed ID: 31507021
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of HMGB-1 in the skin lesions of erythema toxicum.
Marchini G; Hultenby K; Nelson A; Yektaei-Karin E; Ståbi B; Lonne-Rahm S; Ulfgren AK; Brismar H
Pediatr Dermatol; 2007; 24(5):474-82. PubMed ID: 17958791
[TBL] [Abstract][Full Text] [Related]
15. Surface free energy characterization of vernix caseosa. Potential role in waterproofing the newborn infant.
Youssef W; Wickett RR; Hoath SB
Skin Res Technol; 2001 Feb; 7(1):10-7. PubMed ID: 11301635
[TBL] [Abstract][Full Text] [Related]
16. Raman spectroscopic analysis of skin penetration and moisturizing effects of Bionics vernix caseosa cream compared with Vaseline.
Meng H; Yin Y; Wu W; Liu Y; Li L; Dong Y; Fan Y; Li Y; He Y
Technol Health Care; 2021; 29(S1):327-334. PubMed ID: 33682769
[TBL] [Abstract][Full Text] [Related]
17. Epidermal barrier treatments based on vernix caseosa.
Visscher MO; Barai N; LaRuffa AA; Pickens WL; Narendran V; Hoath SB
Skin Pharmacol Physiol; 2011; 24(6):322-9. PubMed ID: 21822033
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of epidermal innate immunity in premature and full-term infants.
Narendran V; Visscher MO; Abril I; Hendrix SW; Hoath SB
Pediatr Res; 2010 Apr; 67(4):382-6. PubMed ID: 20032813
[TBL] [Abstract][Full Text] [Related]
19. Proteome analysis of vernix caseosa.
Tollin M; Jägerbrink T; Haraldsson A; Agerberth B; Jörnvall H
Pediatr Res; 2006 Oct; 60(4):430-4. PubMed ID: 16940245
[TBL] [Abstract][Full Text] [Related]
20. Water-handling properties of vernix caseosa and a synthetic analogue.
Tansirikongkol A; Visscher MO; Wickett RR
J Cosmet Sci; 2007; 58(6):651-62. PubMed ID: 18305878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
